Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
09/13/2012 | CA2829187A1 Dipyridylamine derivative |
09/13/2012 | CA2829159A1 Nutraceutical composition for limiting the absorption of dietary lipids and for inducing weight loss, comprising, as active agent, at least one extract of carrot |
09/13/2012 | CA2829082A1 Heterocyclic modulators of lipid synthesis |
09/13/2012 | CA2828415A1 Substituted morpholines as modulators for the calcium sensing receptor |
09/13/2012 | CA2828411A1 Vectors conditionally expressing protein |
09/13/2012 | CA2826674A1 Tfeb phosphorylation inhibitors and uses thereof |
09/13/2012 | CA2825077A1 1,4 thiazepines/sulfones as bace1 and/or bace2 inhibitors |
09/12/2012 | EP2497488A1 Method for treating delayed-type hypersensitivity reactions associated with changes of qualitative and/or quantitative composition of blood extracellular DNA |
09/12/2012 | EP2497487A1 Method for treating diabetes and atherosclerosis associated with changes of qualitative and/quantitative composition of blood extracellular DNA |
09/12/2012 | EP2497486A1 Method for treating diseases caused by fungi associated with changes of qualitative and/quantitative composition of blood extracellular DNA |
09/12/2012 | EP2497484A2 A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
09/12/2012 | EP2497469A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder |
09/12/2012 | EP2496559A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
09/12/2012 | EP2496232A1 A method to enhance endurance |
09/12/2012 | EP2496213A2 Pharmaceutical solution of non covalently bound albumin and acylated insulin |
09/12/2012 | EP2496096A1 Method of manufacturing magnoliidae compounds |
09/12/2012 | CN102666586A Drug fusions and conjugates with extended half life |
09/12/2012 | CN102666580A Glycosylated form of antigenic GLP-1 analogue |
09/12/2012 | CN102666553A Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts |
09/12/2012 | CN102666543A Inhibitors of diacylglycerol acyltransferase |
09/12/2012 | CN102666500A Seven-membered ring compound and pharmaceutical use therefor |
09/12/2012 | CN102666491A Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
09/12/2012 | CN102666485A Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia |
09/12/2012 | CN102665752A Oxyntomodulin peptide analogue |
09/12/2012 | CN102665750A Nutritional composition beneficial to small intestine |
09/12/2012 | CN102665737A Bifidobacterium longum ATCC BAA-999 (BL999) and weight control |
09/12/2012 | CN102665735A Therapeutic gas for the treatment of mitochondrial disorders |
09/12/2012 | CN102665725A Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages |
09/12/2012 | CN102665724A Composition containing protopanaxatriol and protopanaxadiol |
09/12/2012 | CN102665710A Agent for inhibiting decrease of visceral fat in patient with Parkinson's disease |
09/12/2012 | CN102665676A Pharmaceutical solution of non-covalently bound albumin and acylated insulin |
09/12/2012 | CN102660491A Gene engineering bacteria high-efficiently expressing recombined human glucagon-like peptide-1 (1-37) and construction method and application thereof |
09/12/2012 | CN102660419A Multifunctional health-care wine |
09/12/2012 | CN102659945A Anti-C5aR antibodies and uses thereof |
09/12/2012 | CN102659944A IL-18 binding proteins |
09/12/2012 | CN102659938A Glucagon-like-peptide-2 (GLP-2) analogues |
09/12/2012 | CN102659904A Preparation method for hederagenin and salts thereof |
09/12/2012 | CN102659844A Cr (III) chelate, and preparation method and application thereof |
09/12/2012 | CN102659840A Imidazole diphosphonie acid compound and pharmaceutically-acceptable salt and medicinal application thereof |
09/12/2012 | CN102659813A 2-((2-(3-aminopiperidine-1)-4-oxythiophene (3, 2-d) pyrimidine-3(4H)-methyl) polymorphic benzonitrile, and preparation method and pharmacological applications thereof |
09/12/2012 | CN102659659A Heterocyclic compound having inhibitory activity on 11-beta-hydroxysteroid dehydrogenase type I |
09/12/2012 | CN102659609A Fenofibric acid salt, and preparation method, application and medicinal composition thereof |
09/12/2012 | CN102659570A Difluoro fenofibrate acid and pharmaceutically acceptable salt thereof as well as preparation method and application thereof |
09/12/2012 | CN102657871A Oral slow release preparation, entrapment material and preparation method |
09/12/2012 | CN102657868A 5-hydroxy tryptamine 2 receptor antagonist or transporter inhibitor for treating fatty liver or hyperlipemia |
09/12/2012 | CN102657802A Traditional Chinese medicine for treating diabetic feet |
09/12/2012 | CN102657774A Traditional Chinese medicine for treating diabetic hypertension |
09/12/2012 | CN102657749A Antilipemic Chinese thorowax root pill |
09/12/2012 | CN102657720A Traditional Chinese medicine for treating diabetic dyslipidemia |
09/12/2012 | CN102657719A Chinese medicinal preparation for treating hyperlipidemia |
09/12/2012 | CN102657693A SH2-containing tyrosine phosphatase 1(SHP-1) inhibitor and preparation thereof |
09/12/2012 | CN102657681A Method for preparing deer collagen cream |
09/12/2012 | CN102657678A Composition of potassium chloride and glucose and preparation method for composition |
09/12/2012 | CN102657663A Fat-soluble composite vitamin I composition freeze-dried powder injection and preparation method thereof |
09/12/2012 | CN102657662A Fat-soluble composite vitamin II composition freeze-dried powder injection and preparation method thereof |
09/12/2012 | CN102657656A Composition and methods for modulating a kinase cascade |
09/12/2012 | CN102657643A Composite organic acid-calcium effervescent tablet and preparation method thereof |
09/12/2012 | CN102657640A PTP1B (protein tyrosine phosphatase 1B) inhibition activity of norathyriol, and application of norathyriol |
09/12/2012 | CN102657639A Application of carthamin yellow to aspects of reducing fat and increasing sensitivity of insulin |
09/12/2012 | CN102657637A New application of synephrine |
09/12/2012 | CN102657632A Levocarnitine coating tablet and preparation method thereof |
09/12/2012 | CN102657628A Medicinal composition containing simvastatin and preparation method thereof |
09/12/2012 | CN102657626A Medicinal composite tablet of pioglitazone medicine |
09/12/2012 | CN102657606A Lipoic acid injection for intravenous administration |
09/12/2012 | CN102657329A Soluble tremella combination drink and preparation method thereof |
09/12/2012 | CN102049044B Calcium supplementing composition preparation for improving calcium absorption |
09/12/2012 | CN102020545B PTP1B inhibitor, synthesis and application thereof |
09/12/2012 | CN102020541B Protein tyrosine phosphatase 1B (PTP1B) inhibitor as well as chemical synthesis method and application thereof |
09/12/2012 | CN102020539B PTP1B (Protein Tyrosine Phosphatase 1B) inhibitor, synthesis and application thereof in preparation of drugs for treating type 2 diabetes mellitus |
09/12/2012 | CN101869699B Preparation process of bone peptide soft capsule |
09/12/2012 | CN101760446B Method for preparing monocyte type stem cell and application |
09/12/2012 | CN101628110B Use of fungal immunomodulatory protein |
09/12/2012 | CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase |
09/12/2012 | CN101410131B Lipid-metabolism-improving agent |
09/12/2012 | CN101257900B Gsk-3 inhibitors |
09/11/2012 | US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide |
09/11/2012 | US8263634 Heteroaryl-ureas and their use as glucokinase activators |
09/11/2012 | US8263615 Bis-heterocyclic imidazolyl compounds |
09/11/2012 | US8263609 Tetrahydro-β-carbolin-sulfonamide derivatives as 5-Ht6 ligands |
09/11/2012 | US8263601 Deuterium substituted xanthine derivatives |
09/11/2012 | US8263597 Indazole compounds as CCR1 receptor antagonists |
09/11/2012 | US8263554 Methods of using GLP-1 receptor agonists to treat pancreatitis |
09/11/2012 | US8263545 GIP analog and hybrid polypeptides with selectable properties |
09/11/2012 | US8263121 Solid pharmaceutical preparation |
09/11/2012 | US8262054 Furnace mount |
09/11/2012 | CA2567479C Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight |
09/11/2012 | CA2508573C Novel coumarins, their carboxamide derivatives, preparation methods, compositions, and uses |
09/11/2012 | CA2462557C Method of stabilizing reduced coenzyme q10 |
09/11/2012 | CA2326407C Retroviral vectors including modified envelope escort proteins |
09/11/2012 | CA2257247C Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same |
09/07/2012 | WO2012119078A2 COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE |
09/07/2012 | WO2012119046A2 Heterocyclic compounds for the inhibition of pask |
09/07/2012 | WO2012119007A1 Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders |
09/07/2012 | WO2012118154A1 Novel vitamin d receptor modulator with partial agonist activity |
09/07/2012 | WO2012117996A1 Gpr119 agonist |
09/07/2012 | WO2012117236A1 Vitamin d composition |
09/07/2012 | WO2012117216A1 N- (arylalkyl) - 1h- indole- 2 - sulfonic acid amide compounds and their therapeutic use as cannabinoid allosteric modulators |
09/07/2012 | WO2012116629A1 Mangiferin aglycon derivative and preparation method and use thereof |
09/07/2012 | WO2012116621A1 Optically controlled gene expression system |
09/07/2012 | WO2012116586A1 2-aminothiazole derivative, preparation method, and use |